Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10223-10237
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10223
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10223
Ref. | No. of patients | Selection criteria | Survival rate at 5 yr |
Mazzaferro et al[18] 1996 | 48 | Milan criteria: single HCC < 5 cm or up to 3 nodules < 3 cm | 75% (4 yr) |
Yao et al[19] 2001 | 70 | UCSF criteria: a maximum tumor size of 6.5 cm or 2 lesions ≤ 4.5 cm in diameter with a total tumor diameter of ≤ 8 m | 75% |
Kwon et al[86] 2007 | 114 | HCC ≤ 5 cm | 87% |
AFP ≤ 400 ng/mL | |||
Lee et al[87] 2008 | 186 | Up to 6 nodules with a maximum diameter of < 5 cm | 76% |
Mazzaferro et al[21] 2009 | 283 | Up to 7 criteria: 7 as the sum of the largest size (cm) and the number of tumors | 71% |
Herrero et al[88] 2001 | 154 | HCC ≤ 6 cm or ≤ 3 HCC ≤ 5 cm | 73% |
Jonas et al[89] 2007 | 21 | Any number, each ≤ 6 cm with cumulated diameter ≤ 15 cm | 62% at 3 yr |
Toso et al[90] 2008 | 288 | TTV ≤ 115 cm3 | 72% |
Sugawara et al[91] 2007 | 78 | ≤ 5 HCC ≤ 5 cm | 70% at 3 yr |
- Citation: Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol 2014; 20(30): 10223-10237
- URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10223.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i30.10223